Fortitude Family Office’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9
Closed -$224 2159
2025
Q2
$224 Buy
+9
New +$253 ﹤0.01% 1951

Other funds holding ASTH

Fortitude Family Office's ASTH Position: Q3 2025 in Review

Fortitude Family Office sold out of Astrana Health (ASTH) in Q3 2025, closing a stake of 9 shares — an estimated $224 sold.

Fortitude Family Office first reported a position in ASTH in Q2 2025 and held it in 1 quarter. The position peaked at $224 in Q2 2025. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Fortitude Family Office reported no remaining Astrana Health position as of Q3 2025 after selling out during the quarter.
  • Fortitude Family Office sold 9 Astrana Health shares in Q3 2025, an estimated $224.
  • Fortitude Family Office first reported a position in Astrana Health in Q2 2025 and held it in 1 quarter.
  • Fortitude Family Office's Astrana Health position peaked at $224 in Q2 2025.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Fortitude Family Office's 13F filing for Q3 2025, filed 17 Oct 2025.